Dr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus

Articles by Dr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus

A Conversation about Somatic, Incidental Germline, and Standalone Germline Testing in Clinical Practice

ByDr. Calvin Chao, Sr. Vice President of Medical Affairs at Tempus,Dr. Judy Garber, Chief of the Division for Cancer Genetics and Prevention at Dana-Farber Cancer

June 7th 2021

Sponsored Content by Tempus

Latest Updated Articles

A Conversation about Somatic, Incidental Germline, and Standalone Germline Testing in Clinical Practice
June 7th 2021

Trending on OncLive

Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC

Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma

Five Under 5: Top Oncology Videos for the Week of 9/20

FDA Grants Priority Review to Perioperative Durvalumab Plus Neoadjuvant Enfortumab Vedotin in MIBC

Iberdomide Plus Daratumumab/Dexamethasone Improves MRD-Negative CR vs DVd in Relapsed/Refractory Myeloma